Vaxart Inc. (VXRT): Price and Financial Metrics
VXRT Price/Volume Stats
| Current price | $0.61 | 52-week high | $1.54 |
| Prev. close | $0.62 | 52-week low | $0.52 |
| Day low | $0.60 | Volume | 882,700 |
| Day high | $0.63 | Avg. volume | 2,489,459 |
| 50-day MA | $0.79 | Dividend yield | N/A |
| 200-day MA | $0.86 | Market Cap | 107.84M |
VXRT Stock Price Chart Interactive Chart >
Vaxart Inc. (VXRT) Company Bio
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
VXRT Price Returns
| 1-mo | -22.72% |
| 3-mo | -35.62% |
| 6-mo | -29.59% |
| 1-year | -15.40% |
| 3-year | -91.11% |
| 5-year | 120.77% |
| YTD | 6.49% |
| 2023 | -40.39% |
| 2022 | -84.67% |
| 2021 | 9.81% |
| 2020 | 1,529.10% |
| 2019 | -81.36% |
Continue Researching VXRT
Here are a few links from around the web to help you further your research on Vaxart Inc's stock as an investment opportunity:Vaxart Inc (VXRT) Stock Price | Nasdaq
Vaxart Inc (VXRT) Stock Quote, History and News - Yahoo Finance
Vaxart Inc (VXRT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...